Trial
NCT05242588
Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients With Active Nr-axSpA
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Shanghai Junshi Bioscience Co., Ltd.
Collaborators
Sponsor GmbH
Condition
Non-radiographic Axial Spondyloarthritis
Intervention
JS005
Why stopped
Company research and development strategy adjustment, decided to study temporarily
Provenance
Dataset: 2026-07-24 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-21